FDMT

10.1705.13%
KH

Kristian Humer

Chief Financial Officer

Mr. Kristian Humer, MBA, is serves as CFO of 4D Molecular Therapeutics, Inc. from November 2026 served as CFO & Principal Financial Officer of 4D Molecular Therapeutics, Inc. from November 17, 2025 until November 2026 and also served as its Principal Accounting Officer since March 25, 2026 until November 2026. Mr. Humer joined the 4D Molecular Therapeutics, Inc. on November 17, 2025. He leads the Company’s financial strategy and operations, including responsibility for financial planning, capital allocation, corporate development and supporting strategic initiatives. Mr. Humer is an accomplished finance executive and biotechnology leader with more than two decades of experience spanning corporate finance, strategic operations and healthcare investment banking. He was Chief Financial Officer of Foghorn Therapeutics Inc. since April 16, 2024 until November 14, 2025. He had been a Chief Financial Officer, Chief Business Officer, Principal Financial Officer & Principal Accounting Officer of Viridian Therapeutics, Inc. from July 26, 2021 until September 12, 2023. He had been an Independent Director at Sensei Biotherapeutics, Inc. since July 2021 until June 12, 2026. He spent years on Wall Street, including years as a life science-focused investment banker. He brings significant experience in capital raising, mergers and acquisitions and Partnering to Viridian. He served as Managing Director of Banking, Capital Markets and Advisory for the Global Healthcare team at Citigroup Inc., from January 2017 to July 2021. He previously served in a number of roles at Citigroup Inc., including Director, Healthcare Investment Banking from January 2014 to December 2016, Vice President, Healthcare Investment Banking from January 2011 to December 2013 and Associate, Healthcare Investment Banking from January 2010 to December 2010. Prior to joining Citigroup Inc., Mr. Humer served as Vice President and Associate in the Investment Banking Division for the Global Healthcare team at Lehman Brothers, Inc. from July 2007 to December 2009. Mr. Humer served in various roles at Citigroup Global Markets Inc., including most recently as Managing Director in the Healthcare Investment Banking Group from December 2016 to July 2021. Mr. Humer started his career serving positions of increasing responsibility in the investment banking and private banking divisions of UBS AG and Merrill Lynch (a Bank of America company). He received an MBA from the Fuqua School of Business at Duke University and a B.A. (Hons) in Accounting & Economics from the University of Reading, United Kingdom.

Positions